These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 12535076)

  • 41. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
    Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
    J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
    Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Gnr1p, a negative regulator of G alpha signalling in Schizosaccharomyces pombe, and its complementation by human G beta subunits.
    Goddard A; Ladds G; Forfar R; Davey J
    Fungal Genet Biol; 2006 Dec; 43(12):840-51. PubMed ID: 16884933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors.
    Minic J; Sautel M; Salesse R; Pajot-Augy E
    Curr Med Chem; 2005; 12(8):961-9. PubMed ID: 15853708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
    Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
    J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
    Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
    Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
    Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
    J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in discrimination of closely related pheromones in Schizosaccharomyces pombe.
    Seike T; Sakata N; Shimoda C; Niki H; Furusawa C
    Genetics; 2021 Dec; 219(4):. PubMed ID: 34849842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding Corticotropin Releasing Factor Receptor (CRFR) Activation Using Structural Models.
    Cordomi A; Liapakis G; Matsoukas MT
    Curr Mol Pharmacol; 2017; 10(4):325-333. PubMed ID: 28103783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional analysis of heterologous GPCR signalling pathways in yeast.
    Ladds G; Goddard A; Davey J
    Trends Biotechnol; 2005 Jul; 23(7):367-73. PubMed ID: 15923053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.
    Van Kolen K; Dautzenberg FM; Verstraeten K; Royaux I; De Hoogt R; Gutknecht E; Peeters PJ
    Neuropharmacology; 2010 Jan; 58(1):135-44. PubMed ID: 19573542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
    Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
    J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional Significance of the Signal Peptides of Corticotropin-Releasing Factor Receptors.
    Schulein R; Gibert A; Rutz C
    Curr Mol Pharmacol; 2017; 10(4):311-317. PubMed ID: 28240192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
    Traver S; Marien M; Martin E; Hirsch EC; Michel PP
    Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.